APA
Bancroft E. K., Saya S., Page E. C., Myhill K., Thomas S., Pope J., Chamberlain A., Hart R., Glover W., Cook J., Rosario D. J., Helfand B. T., Hutten Selkirk C., Davidson R., Longmuir M., Eccles D. M., Gadea N., Brewer C., Barwell J., Salinas M., Greenhalgh L., Tischkowitz M., Henderson A., Evans D. G., Buys S. S., Eeles R. A. & Aaronson N. K. (20190927). Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations. : BJU international.
Chicago
Bancroft Elizabeth K, Saya Sibel, Page Elizabeth C, Myhill Kathryn, Thomas Sarah, Pope Jennifer, Chamberlain Anthony, Hart Rachel, Glover Wayne, Cook Jackie, Rosario Derek J, Helfand Brian T, Hutten Selkirk Christina, Davidson Rosemarie, Longmuir Mark, Eccles Diana M, Gadea Neus, Brewer Carole, Barwell Julian, Salinas Monica, Greenhalgh Lynn, Tischkowitz Marc, Henderson Alex, Evans David Gareth, Buys Saundra S, Eeles Rosalind A and Aaronson Neil K. 20190927. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations. : BJU international.
Harvard
Bancroft E. K., Saya S., Page E. C., Myhill K., Thomas S., Pope J., Chamberlain A., Hart R., Glover W., Cook J., Rosario D. J., Helfand B. T., Hutten Selkirk C., Davidson R., Longmuir M., Eccles D. M., Gadea N., Brewer C., Barwell J., Salinas M., Greenhalgh L., Tischkowitz M., Henderson A., Evans D. G., Buys S. S., Eeles R. A. and Aaronson N. K. (20190927). Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations. : BJU international.
MLA
Bancroft Elizabeth K, Saya Sibel, Page Elizabeth C, Myhill Kathryn, Thomas Sarah, Pope Jennifer, Chamberlain Anthony, Hart Rachel, Glover Wayne, Cook Jackie, Rosario Derek J, Helfand Brian T, Hutten Selkirk Christina, Davidson Rosemarie, Longmuir Mark, Eccles Diana M, Gadea Neus, Brewer Carole, Barwell Julian, Salinas Monica, Greenhalgh Lynn, Tischkowitz Marc, Henderson Alex, Evans David Gareth, Buys Saundra S, Eeles Rosalind A and Aaronson Neil K. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations. : BJU international. 20190927.